Plant-based drugs come with lower development cost

08/17/2014 | Reuters

Companies including Mapp Pharmaceutical, Icon Genetics and PlantForm are looking to produce antibodies, drugs and vaccines from plants, which offer a lower cost of production. The technique has yet to catch on with major drugmakers.

View Full Article in:


Published in Brief: